Kadimastem Ltd
KDST
Rangering i aksjer
#40954
Kadimastem Ltd is a biopharmaceutical company focused on pioneering... Kadimastem Ltd is a biopharmaceutical company focused on pioneering regenerative medical treatments. These therapies are developed using cells sourced from human embryonic stem cells, primarily targeting neurodegenerative diseases. Its development pipeline features AstroRx, a clinical-grade human astrocyte product currently undergoing Phase 1/2a clinical trials for amyotrophic lateral sclerosis (ALS) and various other neurodegenerative conditions. Additionally, the company is advancing IsletRx, a clinical-grade pancreatic islet cell therapy intended for the treatment of diabetes. Incorporated in 2008, Kadimastem is headquartered in Ness Ziona, Israel.
Aksjekurs
$12.16
Sist synkronisert: 2025-10-30
Markedsverdi
$50.98K
Endring (1 dag)
-0.10%
Endring (1 år)
69.56%
Land
IL
Handel Kadimastem Ltd (KDST)
Kategori
Healthcare
Historikk for aksjesplitt for Kadimastem Ltd (KDST)
Aksjen Kadimastem Ltd (symbol: KDST) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Oct 20, 2026.
Én KDST-aksje kjøpt før Oct 20, 2026 tilsvarer i dag 0 KDST-aksjer.
Den nyeste splittelsen skjedde Oct 20, 2026.
Én KDST-aksje kjøpt før Oct 20, 2026 tilsvarer i dag 0 KDST-aksjer.
Liste over aksjesplitt
| År | Splitt | Multiplikator | Kumulativ multiplikator |
|---|---|---|---|
| Ikke nok data for de angitte datoene. | |||
Aksjesplitt for lignende selskaper eller konkurrenter
| Selskap | Antall aksjesplitt | Kumulativ multiplikator | Land |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
